Our current investments range from companies that are involved in but limited to:
- Medical Research
- Green Tech
We maintain investments in a wide and well-balanced portfolio of venture capital opportunities, adhering to a technology and industry tentative approach.
The opportunities we carefully analyse exhibit the following attributes:
- An entity seeking to raise between $0.5 million to $10 million.
- An existing book value of less than $50 million.
- An investment time line of between 3 to 5 years.
- Being prepared to supply Thomas Markgraf with an equity stake of substantial proportion; inclusive of shareholder projections and significant reputation at board level.
- Characteristics exuding rapid growth in early expansion through to late VC stage.
- Possessing a clear and defined competitive advantage/market edge, enabling national and/or international competitiveness within its sector.